Testing effectiveness (Phase 2)UnknownNCT05029973
What this trial is testing
HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC
Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30